Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond.
Ma TM, Roy S, Wu X, Mantz C, Fuller D, Miszczyk L, Napieralska A, Namysł-Kaletka A, Bagshaw HP, Buyyounouski MK, Glicksman R, Loblaw DA, Katz A, Upadhyaya SK, Nickols N, Steinberg ML, Philipson R, Aghdam N, Suy S, Pepin A, Collins SP, Boutros P, Rettig MB, Calais J, Wang M, Zaorsky N, Kishan AU. Ma TM, et al. Among authors: loblaw da. Radiother Oncol. 2022 Jan;166:1-7. doi: 10.1016/j.radonc.2021.11.005. Epub 2021 Nov 11. Radiother Oncol. 2022. PMID: 34774650
Re-irradiation for locally recurrent nasopharyngeal carcinoma.
McLean M, Chow E, O'Sullivan B, Munro A, Leung PM, Loblaw DA, Panzarella T. McLean M, et al. Among authors: loblaw da. Radiother Oncol. 1998 Aug;48(2):209-11. doi: 10.1016/s0167-8140(98)00052-8. Radiother Oncol. 1998. PMID: 9783894
Assessing individual risk for prostate cancer.
Nam RK, Toi A, Klotz LH, Trachtenberg J, Jewett MA, Appu S, Loblaw DA, Sugar L, Narod SA, Kattan MW. Nam RK, et al. Among authors: loblaw da. J Clin Oncol. 2007 Aug 20;25(24):3582-8. doi: 10.1200/JCO.2007.10.6450. J Clin Oncol. 2007. PMID: 17704405
Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3.
Tang CI, Loblaw DA, Cheung P, Holden L, Morton G, Basran PS, Tirona R, Cardoso M, Pang G, Gardner S, Cesta A. Tang CI, et al. Among authors: loblaw da. Clin Oncol (R Coll Radiol). 2008 Dec;20(10):729-37. doi: 10.1016/j.clon.2008.08.006. Epub 2008 Oct 5. Clin Oncol (R Coll Radiol). 2008. PMID: 18838256 Clinical Trial.
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline.
Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, Ray M, Sandler H. Morgan SC, et al. Among authors: loblaw da. J Clin Oncol. 2018 Oct 11;36(34):JCO1801097. doi: 10.1200/JCO.18.01097. Online ahead of print. J Clin Oncol. 2018. PMID: 30307776 Free PMC article. No abstract available.
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline.
Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, Ray M, Sandler H. Morgan SC, et al. Among authors: loblaw da. Pract Radiat Oncol. 2018 Nov-Dec;8(6):354-360. doi: 10.1016/j.prro.2018.08.002. Epub 2018 Oct 11. Pract Radiat Oncol. 2018. PMID: 30322661
87 results